Clinical Trial Update: A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pharyngeal immunity to Poliovirus Type-2 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Snippet

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED